Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Michael, Kurowski"'
Autor:
Peter Kotzerke, Christoph Stephan, Martin Stürmer, Markus Bickel, Pavel Khaykin, Michael Kurowski, Nils von Hentig, Reinhard Brodt, Gabi Nisius, Annette Haberl
Publikováno v:
Therapeutic Drug Monitoring. 36:192-201
Objective Lopinavir/ritonavir plus nucleoside reverse transcriptase inhibitors is one standard antiretroviral therapy regimen, both in patients with HIV alone and coinfected with hepatitis B or C. Our objective was to investigate whether hepatitis co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f079f2461fb738b5ce301a22b863fbdf
https://doi.org/10.1097/ftd.0b013e3182a28c6a
https://doi.org/10.1097/ftd.0b013e3182a28c6a
Autor:
Glynn A. Morrish, Gerd Faetkenheuer, Bruce Green, Markus Bickel, Michael Kurowski, Yvon van Delft, Thomas N. Kakuda, Andrew Hill, Giovanni Di Perri
Publikováno v:
HIV Clinical Trials. 14:92-98
Etravirine is currently approved for HIV treatment-experienced patients at a dose of 200 mg twice daily. The long terminal elimination half-life of etravirine should support once-daily dosing.In the double-blind 48-week SENSE trial, 157 antiretrovira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9978147638dafa52ed1bc92efb1ea51
https://doi.org/10.1310/hct1403-92
https://doi.org/10.1310/hct1403-92
Autor:
Thomas A. Lutz, Wolf O. Bechstein, Nils von Hentig, Johannes Kuetscher, Evrim Anadol, Jürgen K. Rockstroh, Markus Bickel, Hans Reinhard Brodt, Wolf Peter Hofmann, Martin Vogel, C. Moench, Michael Kurowski, Tessa Lennemann
Publikováno v:
Journal of Antimicrobial Chemotherapy. 65:999-1004
The number of HIV-infected patients receiving orthotopic liver transplantation (OLTX) is increasing. One major challenge is the severe drug-drug interactions between immunosuppressive drugs such as tacrolimus and ritonavir-boosted HIV-1 protease inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063e3745cb81949ee0dc37112a593f0f
https://doi.org/10.1093/jac/dkq054
https://doi.org/10.1093/jac/dkq054
Autor:
Rose Kabasinguzi, Michael Kurowski, Andrea Kunz, Charlotte Kloft, Kizito Mugenyi, Monika Frank, Gundel Harms, Astrid Weidenhammer
Publikováno v:
Journal of Antimicrobial Chemotherapy. 63:170-177
OBJECTIVES: Nevirapine is widely used in the developing world for the prevention of mother-to-child transmission (PMTCT) of HIV. A single mutation in the HIV genome is sufficient to lead to significant nevirapine resistance. Persistence of low-level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ced294bd86b489793ba4f9fa43733ce9
https://doi.org/10.1093/jac/dkn441
https://doi.org/10.1093/jac/dkn441
Autor:
Angelika Mayer, Shirin Simo, Kizito Mugenyi, Gundel Harms, Moses Ali, Heiko Karcher, Andrea Kunz, Michael Kurowski
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 44:562-565
Background: Intrapartum transmission of HIV has been reported to be associated with HIV in oropharyngeal secretions (OPSs) of the child. In this study, we analyze the frequency of intrapartum transmission after mucosal exposure to HIV after administr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdcbcc79e6fb3d51dffed1c093b803a2
https://doi.org/10.1097/qai.0b013e31802f853f
https://doi.org/10.1097/qai.0b013e31802f853f
Autor:
Michael Kurowski, Sebastian Harder, Timo Wolf, Nils von Hentig, Schlomo Staszewski, Thomas A. Lutz, S Klauke, Brenda Dauer, Carsten Rottmann, Bruno G. Oertel, Axel Müller
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:1431-1439
The objective of this study was to evaluate the pharmacokinetics of atazanavir (ATV), saquinavir (SQV), and ritonavir (RTV) in a boosted double-protease inhibitor (PI) therapy regimen without reverse transcriptase inhibitors (RTIs). The study design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5fbcab68d4291457c513306b5037ff
https://doi.org/10.1128/aac.00854-06
https://doi.org/10.1128/aac.00854-06
Autor:
Annette Haberl, Michael Kurowski, Schlomo Staszewski, Christoph Stephan, Brenda Dauer, Carsten Rottmann, Amina Carlebach, N von Hentig
Publikováno v:
International Journal of STD & AIDS. 18:81-84
Gastrointestinal intolerance is a limitation of boosted saquinavir antiretroviral treatment. We present three HIV-infected individuals whose severe toxicity symptoms started directly after initiation of a standard dose saquinavir hard-gel capsule-con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c1aa19b9bd7f0b2d58d7ed02d7bf909
https://doi.org/10.1258/095646207779949763
https://doi.org/10.1258/095646207779949763
Autor:
Edward P. Acosta, Mario Regazzi, David M. Burger, Courtney V. Fletcher, David Back, Marta Boffito, Gilles Peytavin, Carlo Federico Perno, Rodolphe Garaffo, Charles Flexner, Giorgio Gatti, Michael Kurowski
Publikováno v:
Antiviral Therapy. 10:469-477
The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) provide a framework for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3538d77da1bb72448ba169a84a626fd2
https://doi.org/10.1177/135965350501000413
https://doi.org/10.1177/135965350501000413
Autor:
Marta Boffito, Rodolphe Garaffo, David Back, Gilles Peytavin, Giorgio Gatti, Edward P. Acosta, Michael Kurowski, Mario Regazzi, Carlo Federico Perno, Courtney V. Fletcher, David M. Burger, Charles Flexner
Publikováno v:
Scopus-Elsevier
Antiviral Therapy, 10, 3, pp. 375-92
Europe PubMed Central
Antiviral Therapy, 10, 375-92
Antiviral Therapy, 10, 3, pp. 375-92
Europe PubMed Central
Antiviral Therapy, 10, 375-92
The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors and protease inhibitors provide a framework for the implementati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e128ac27ef3d403ef969c2a1cf82291e
https://doi.org/10.1177/135965350501000307
https://doi.org/10.1177/135965350501000307
Autor:
Andrew F. Hill, Graeme Moyle, Brian Gazzard, Mark Nelson, Marta Boffito, Andrew A Benzie, Guido Kruse, Anton Pozniak, Michael Kurowski
Publikováno v:
AIDS. 18:1291-1297
Objective: To determine the pharmacokinetics of saquinavir hard-gel capsules/ ritonavir/atazanavir co-administered once daily at 1600/100/300 mg in HIV-infected individuals. Methods: Eighteen patients receiving saquinavir/ritonavir switched to 1600/1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae6663480cd0692af85eee22dc428955
https://doi.org/10.1097/00002030-200406180-00007
https://doi.org/10.1097/00002030-200406180-00007